Torres J-M JM - OmicsDI

Show results for

Unknown (1084)
Proteomics (11)
Metabolomics (7)
Transcriptomics (2)

Organisms

Homo sapiens (8)
Mus musculus (3)
Rattus norvegicus (2)
Homo (1)

Repository

pride (11)
MetaboLights (7)
biostudies-arrayexpress (2)

Tissue

Liver (3)
Cell culture (2)
Blood (1)
Blood plasma (1)
Blood platelet (1)
Blood serum (1)
Brain (1)
Colon (1)
Dentin (1)
Heart (1)
Hepatocyte (1)
Lymph node (1)
Megakaryocyte (1)
Platelet (1)
Tooth (1)
Tooth enamel (1)

Disease

Disease of metabolism (1)
Liver disease (1)
Melanoma (1)
Primary sclerosing cholangitis (1)
Thyroid cancer (1)
Ulcerative colitis (1)

Technology Type

Mass Spectrometry (11)
Shotgun proteomics (7)
Mass spectrometry (6)
Bottom-up proteomics (3)
Data-independent acquisition (2)
Mass spectrometry assay (1)
Data-dependent acquisition (1)
DiaPASEF (1)
Gel-based experiment (1)
SRM/MRM (1)
SWATH MS (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (5)
Gas Chromatography MS - positive (1)
Liquid Chromatography MS - positive (1)

Publication Date

2023 (5)
2024 (2)
2026 (2)
2022 (2)
2021 (2)
2017 (2)
2014 (1)
2013 (1)
2025 (1)
2020 (1)
2019 (1)

CHEBI ID

CHEBI:16359 (3)
CHEBI:28865 (3)
CHEBI:35038 (3)
CHEBI:139138 (2)
CHEBI:143745 (2)
CHEBI:143757 (2)
CHEBI:16113 (2)
CHEBI:173703 (2)
CHEBI:182784 (2)
CHEBI:195271 (2)
CHEBI:27432 (2)
CHEBI:27997 (2)
CHEBI:28716 (2)
CHEBI:34494 (2)
CHEBI:34687 (2)
CHEBI:64563 (2)
CHEBI:73858 (2)
CHEBI:75342 (2)
CHEBI:80774 (2)
CHEBI:10136 (1)
CHEBI:1148 (1)
CHEBI:116314 (1)
CHEBI:131342 (1)
CHEBI:145227 (1)
CHEBI:15603 (1)
CHEBI:15729 (1)
CHEBI:16015 (1)
CHEBI:16070 (1)
CHEBI:16196 (1)
CHEBI:16235 (1)

Metabolite Name

Cholic acid (3)
Tris(2-butoxyethyl) phosphate (3)
(2S,3S,4S,5R,6R)-6-[[(3S,4S,6aR,6bS,8aR,9R,12aS,14bR)-9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-5-[(2S,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxyoxane-2-carboxylic acid (2)
1-({[2-(2-furylmethyl)-5-methylpyrrolidinyl]amino}methylene)-7-[8-({[2-(2-fury lmethyl)pyrrolidinyl]amino}methylene)-1,6-dihydroxy-3-methyl-5-(methylethyl)-7 -oxo(2-naphthyl)]-3,8-dihydroxy-6-methyl-4-(methylethyl)naphthalen-2-one (2)
1-Stearoyl-2-hydroxy-sn-glycero-3-phosphocholine (2)
2,6-Di-tert-butyl-4-hydroxymethylphenol (2)
9(10)-EpOME (2)
Alpha-linolenic acid|linolenic acid|(9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid (2)
Cholesterol (2)
Dibutyl phthalate (DBP) (2)
Elaidic acid (2)
Lyso-PC(16:0) (2)
Methionine (2)
Monoolein (2)
NCGC00385123-01_C22H30O6_7b,9-Dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1,1a,1b,4,4a,5,7a,7b,8,9-decahydro-9aH-cyclopropa[3,4]benzo[1,2-e]azulen-9a-yl acetate (2)
Taurocholic acid (2)
(R)-4-((3R,4R,5S,8S,9S,10R,13R,14S,17R)-3,4-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid (1)
(R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid (1)
1,3,5-triprop-2-enyl-1,3,5-triazaperhydroine-2,4,6-trione (1)
1,4a-dimethyl-9-oxo-7-propan-2-yl-3,4,10,10a-tetrahydro-2H-phenanthrene-1-carboxylic acid (1)
1,5-Anhydroglucitol (1)
1-(9Z-Octadecenoyl)-sn-glycero-3-phosphocholine (1)
1-Heptadecanoyl-sn-glycero-3-phosphocholine (1)
1-Hexadecanoyl-sn-glycerol (1)
1-Hexadecyl-sn-glycero-3-phosphocholine (1)
1-Myristoyl-2-stearoyl-sn-glycero-3-phosphocholine (1)
1-Myristoyl-sn-glycero-3-phosphocholine (1)
1-Palmitoyl-2-myristoyl-sn-glycero-3-phosphocholine (1)
13(S)-HODE methyl ester (1)
13-Keto-9Z,11E-octadecadienoic acid (1)

Study type

Transcription profiling by array (2)

Release Date

2021 (161)
2022 (151)
2023 (131)
2024 (121)
2025 (107)
2019 (67)
2020 (64)
2018 (54)
2017 (48)
2015 (40)
2016 (33)
2026 (19)
2011 (19)
2014 (18)
2012 (17)
2013 (16)
2010 (11)
2009 (4)
2008 (2)
2004 (2)
2006 (1)

Lab affiliation

Instituto de Investigaciones Marinas (IIM-CSIC) (2)
1. Gene Regulation, Stem Cells and Development group, PTS, Granada GENyO, Pfizer-University of Granada-Andalusian Regional Government Centre for Genomics and Oncological Research, Avenida de la Ilustración 114, 18016 Granada, Spain. 2. Department of Biochemistry and Molecular Biology I, Faculty of Science, University of Granada, Avenida Fuentenueva s/n, 18071 Granada, Spain. 3. Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain. (1)
CNIO (1)
Cardiovascular proteomics group, Spanish National Center for Cardiovascular Research (CNIC), Madrid, 28028, Spain (1)
Department of Medicine (1)
Microenvironment and Metastasis Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain. (1)
Proteomics Core Facility and Research Group Proteomics, CEITEC-MU, Masaryk University, Brno, Czech Republic (1)
Spanish National Cancer Research Center (CNIO) (1)
Spanish National Cancer Research Centre (CNIO) Address: Melchor Fernández Almagro, 3. 28029 Madrid. SPAIN (1)
University of Copenhagen (1)

Previous page
1 / 111
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 111
Next page

Sort by:

Relevance

Page size

Pth4, an ancient parathyroid hormone lost in eutherian mammals, reveals a new brain-to-bone signaling pathway.

Not available

S-EPMC5240660 | biostudies-literature

Models to Predict Hepatitis B Virus Infection Among Patients With Cancer Undergoing Systemic Anticancer Therapy: A Prospective Cohort Study.

Not available

S-EPMC7351320 | biostudies-literature

Regional synapse gain and loss accompany memory formation in larval zebrafish.

Not available

S-EPMC8784156 | biostudies-literature

Metabolomics Analysis Identifies Glutamic acid and Cystine imbalances in COVID-19 Patients Without Comorbid Conditions. Implications on Redox Homeostasis and COVID-19 Pathophysiology

It is well known that the presence of comorbidities and age-related health issues may hide biochemical and metabolic features triggered by SARS-CoV-2 infection and other diseases associated to hypoxia, as they are by themselves chronic inflammatory conditions that may potentially disturb metaboli...

2024-08-26 | MTBLS5011 | MetaboLights

Health services for aboriginal and Torres Strait Islander children in remote Australia: A scoping review.

Not available

S-EPMC10022200 | biostudies-literature

Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma.

Not available

S-EPMC3646316 | biostudies-literature

Role of POLE and POLD1 in familial cancer.

Not available

S-EPMC7708298 | biostudies-literature

Global Profiling in Vestibular Schwannomas Shows Critical Deregulation of MicroRNAs and Upregulation in those included in Chromosomal Region 14q32

Background: Vestibular Schwannomas are benign tumors that arise from Schwann cells in the VIII cranial pair and usually present NF2 gene mutations and/or loss of heterozygosity on chromosome 22q. Deregulation has also been found in several genes, such as ERBB2 and NRG1. MicroRNAs are non-coding RNAs...

ORGANISM(S): Homo sapiens

2014-03-24 | E-GEOD-43571 | biostudies-arrayexpress

Proteomic validation of MEG-01-Derived Extracellular Vesicles as Biologically Representative Models for Megakaryocyte- and Platelet-Derived Extracellular Vesicles.

Platelets and their extracellular vesicles (EVs) have emerged as promising liquid biopsy biosources for cancer detection and monitoring. The megakaryoblastic MEG-01 cell line offers a controlled system for generating platelet-like particles (PLPs) and EVs through valproic acid induced differentiatio...

ORGANISM(S): Homo sapiens (Human)

2026-01-05 | PXD070221 | Pride

Cognitive Impairment in Fall-Related Studies in Parkinson's Disease.

Not available

S-EPMC4923751 | biostudies-literature

Previous page
1 / 111
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 111
Next page

Sort by:

Relevance

Page size

1104 Results

Show results for

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

Study type

Release Date

Lab affiliation

OmicsDI is part of the ELIXIR infrastructure

Tweets